SG35590G - Pyrimidinyl-piperazine derivatives - Google Patents

Pyrimidinyl-piperazine derivatives

Info

Publication number
SG35590G
SG35590G SG355/90A SG35590A SG35590G SG 35590 G SG35590 G SG 35590G SG 355/90 A SG355/90 A SG 355/90A SG 35590 A SG35590 A SG 35590A SG 35590 G SG35590 G SG 35590G
Authority
SG
Singapore
Prior art keywords
pyrimidinyl
piperazine derivatives
piperazine
derivatives
Prior art date
Application number
SG355/90A
Other languages
English (en)
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of SG35590G publication Critical patent/SG35590G/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/12—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/42—One nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Legs For Furniture In General (AREA)
SG355/90A 1984-03-06 1990-05-19 Pyrimidinyl-piperazine derivatives SG35590G (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US58658084A 1984-03-06 1984-03-06
US06/683,309 US4605655A (en) 1984-03-06 1984-12-18 Antipsychotic 1-fluorophenylbutyl-4-(2-pyrimidinyl)piperazine derivatives

Publications (1)

Publication Number Publication Date
SG35590G true SG35590G (en) 1990-07-13

Family

ID=27079753

Family Applications (1)

Application Number Title Priority Date Filing Date
SG355/90A SG35590G (en) 1984-03-06 1990-05-19 Pyrimidinyl-piperazine derivatives

Country Status (27)

Country Link
US (1) US4605655A (hu)
KR (3) KR920005113B1 (hu)
AT (1) AT390951B (hu)
AU (1) AU576555B2 (hu)
BE (1) BE901880A (hu)
CA (1) CA1256871A (hu)
CH (1) CH663022A5 (hu)
CY (1) CY1545A (hu)
DE (1) DE3507983A1 (hu)
DK (1) DK166149C (hu)
ES (1) ES8607254A1 (hu)
FI (1) FI84478C (hu)
FR (1) FR2560878B1 (hu)
GB (1) GB2155925B (hu)
GR (1) GR850561B (hu)
HK (1) HK82890A (hu)
HU (1) HU193949B (hu)
IE (1) IE58338B1 (hu)
IT (1) IT1183483B (hu)
LU (1) LU85796A1 (hu)
MX (1) MX9203177A (hu)
MY (1) MY102240A (hu)
NL (1) NL8500628A (hu)
PT (1) PT80058B (hu)
SE (1) SE462429B (hu)
SG (1) SG35590G (hu)
ZA (1) ZA851486B (hu)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4668687A (en) * 1984-07-23 1987-05-26 Bristol-Myers Company Psychogeriatric 1-(2-pyrimidinyl)piperazinyl derivatives of 1-pyrrolidin-2-ones
US4677104A (en) * 1985-05-06 1987-06-30 Bristol-Myers Company Antipsychotic fused-ring pyridinylpiperazine derivatives
US4766215A (en) * 1987-02-27 1988-08-23 American Home Products Corporation Histamine H1 -receptor antagonists
SE8701375D0 (sv) * 1987-04-02 1987-04-02 Leo Ab Novel pyridyl- and pyrimidyl derivatives
US4826844A (en) * 1987-09-30 1989-05-02 American Home Products Corporation Substituted 1-(aralkyl-piperazinoalkyl) cycloalkanols
MX173180B (es) * 1987-10-26 1994-02-07 Pfizer Procedimiento para preparar agentes ansioliticos
US4882432A (en) * 1989-01-09 1989-11-21 American Home Products Corporation Polycyclic-carbamic acid piperazinoalkyl esters and amides
GB8909209D0 (en) * 1989-04-22 1989-06-07 Wyeth John & Brother Ltd Piperazine derivatives
PT93824B (pt) * 1989-04-22 1996-09-30 Wyeth John & Brother Ltd Processo para a preparacao de derivados de piperazina
US5055470A (en) * 1989-06-01 1991-10-08 Bristol-Myers Squibb Co. Method of treatment of ischemia in brain
US4994460A (en) * 1989-06-01 1991-02-19 Bristol-Myers Squibb Co. Agents for treatment of brain ischemia
FR2672052B1 (fr) * 1991-01-28 1995-05-24 Esteve Labor Dr Derives d'aryl (ou heteroaryl)-piperazinyl-alkyl-azoles, leur preparation et leur application en tant que medicaments.
US5681956A (en) * 1990-12-28 1997-10-28 Neurogen Corporation 4-aryl substituted piperazinylmethyl phenylimidazole derivatives; a new class of dopamine receptor subtype specific ligands
US5656762A (en) * 1990-12-28 1997-08-12 Neurogen Corporation 4-piperidino-and piperazinomethyl-2-phenylimidazole derivatives, dopamine receptor subtype specific ligands
US5512584A (en) * 1991-04-16 1996-04-30 Basf Aktiengesellschaft 1,3,4-trisubstituted piperidine derivatives, the preparation and use thereof
EP0538693A3 (en) * 1991-10-23 1994-08-17 Squibb & Sons Inc Stereoselective preparation of halophenyl alcohols
TW217382B (hu) * 1991-10-24 1993-12-11 Bristol Myers Squibb Co
SE9201239D0 (sv) * 1992-04-21 1992-04-21 Kabi Pharmacia Ab Agents for treating substance abuse disorders
US5324662A (en) * 1992-05-15 1994-06-28 E. R. Squibb & Sons, Inc. Stereoselective microbial or enzymatic reduction of 3,5-dioxo esters to 3-hydroxy-5-oxo, 3-oxo-5-hydroxy, and 3,5-dihydroxy esters
DE4243287A1 (de) * 1992-06-19 1993-12-23 Basf Ag N-Substituierte Azabicycloheptan-Derivate, ihre Herstellung und Verwendung
DE4219973A1 (de) * 1992-06-19 1993-12-23 Basf Ag N-substituierte Azabicycloheptan-Derivate, ihre Herstellung und Verwendung
ES2074946B1 (es) * 1993-07-19 1996-06-16 Ferrer Int Nuevos compuestos derivados de la 1,2-etanodiamina-n,n,n',n'-tetrasustituida.
DE4341403A1 (de) * 1993-12-04 1995-06-08 Basf Ag N-substituierte 3-Azabicycloalkan-Derivate, ihre Herstellung und Verwendung
CA2187542C (en) * 1994-04-18 2000-02-01 Nobuyuki Takahashi Adamantane derivative, process for producing the same, and use thereof
US5607936A (en) * 1994-09-30 1997-03-04 Merck & Co., Inc. Substituted aryl piperazines as neurokinin antagonists
ES2104509B1 (es) * 1995-06-13 1998-07-01 Ferrer Int Nuevos compuestos derivados de 2-(3,4-disustituido-1-piperazinil)-5-fluoropirimidina.
US6166205A (en) * 1998-09-02 2000-12-26 Neurogen Corporation 2-Aryl-4-(1-[4-heteroaryl]piperazin-1-yl)methylimidazoles: dopamine . D.sub4 receptor subtype ligands
US8541409B2 (en) * 2007-05-14 2013-09-24 Sk Biopharmaceuticals Co., Ltd. Carbamoyloxy arylalkanoyl arylpiperazine analgesics
JP6440625B2 (ja) 2012-11-14 2018-12-19 ザ・ジョンズ・ホプキンス・ユニバーシティー 精神分裂病を処置するための方法および組成物
WO2021236879A1 (en) 2020-05-20 2021-11-25 The Board Of Trustees Of The University Of Illinois Method for treating lysosomal storage diseases with histatin peptides

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2979508A (en) * 1959-10-12 1961-04-11 Paul A J Janssen Heterocyclic derivatives of 1-phenyl-omega-(piperazine) alkanols
US2985657A (en) * 1959-10-12 1961-05-23 Paul A J Janssen 1-(aroylalkyl)-4-heterocyclylpiperazines
US2973360A (en) * 1959-10-12 1961-02-28 Paul A J Janssen Certain 1-(2-theonyl lower alkyl)-4-(heterocyclic substituted)-piperazines
NL127996C (hu) * 1963-11-19
GB1259685A (en) * 1969-04-03 1972-01-12 Soc D Etudes Prod Chimique Amino-pyrimidine derivatives
BE758380A (fr) * 1969-11-04 1971-04-16 Sumitomo Chemical Co Procede de preparation de derives d'aryl-cetones
GB1307256A (en) * 1970-09-15 1973-02-14 Science Union & Cie Piperazine derivatives and a process for their preparation
BE882836A (fr) * 1979-05-15 1980-08-18 Soc D Etudes Prod Chimique Nouveaux derives halogenes de l'isopropylamino pyrimidine, leur preparation et leur utilisaton therapeutique
US4316899A (en) * 1979-08-24 1982-02-23 Beecham Group Limited Chromanone derivatives, a process for their preparation and compositions containing them
DE3321969A1 (de) * 1983-06-18 1984-12-20 Troponwerke GmbH & Co KG, 5000 Köln 2-pyrimidinyl-1-piperazin-derivate, verfahren zu ihrer herstellung und diese enthaltende arzneimittel

Also Published As

Publication number Publication date
KR850006402A (ko) 1985-10-05
IT8519773A0 (it) 1985-03-05
AT390951B (de) 1990-07-25
SE462429B (sv) 1990-06-25
PT80058B (pt) 1987-10-20
IE58338B1 (en) 1993-09-08
SE8501067D0 (sv) 1985-03-05
KR920005114B1 (ko) 1992-06-26
US4605655A (en) 1986-08-12
PT80058A (en) 1985-04-01
ZA851486B (en) 1985-11-27
AU576555B2 (en) 1988-09-01
DK166149C (da) 1993-08-09
FI850850L (fi) 1985-09-07
GB8505662D0 (en) 1985-04-03
DE3507983A1 (de) 1985-09-12
KR920005694B1 (ko) 1992-07-13
FI84478C (fi) 1991-12-10
IT1183483B (it) 1987-10-22
ES540901A0 (es) 1986-05-16
BE901880A (fr) 1985-09-05
HU193949B (en) 1987-12-28
MY102240A (en) 1992-05-15
CA1256871A (en) 1989-07-04
HUT37781A (en) 1986-02-28
DK166149B (da) 1993-03-15
DK100685A (da) 1985-09-07
FR2560878B1 (fr) 1988-10-14
IE850546L (en) 1985-09-06
FI850850A0 (fi) 1985-03-01
GB2155925B (en) 1987-11-25
CH663022A5 (de) 1987-11-13
ATA64985A (de) 1990-01-15
FR2560878A1 (fr) 1985-09-13
HK82890A (en) 1990-10-19
ES8607254A1 (es) 1986-05-16
SE8501067L (sv) 1985-09-07
LU85796A1 (fr) 1985-12-12
NL8500628A (nl) 1985-10-01
DK100685D0 (da) 1985-03-05
FI84478B (fi) 1991-08-30
GB2155925A (en) 1985-10-02
KR920005113B1 (ko) 1992-06-26
GR850561B (hu) 1985-07-03
AU3944985A (en) 1985-09-12
CY1545A (en) 1991-03-22
MX9203177A (es) 1992-07-01

Similar Documents

Publication Publication Date Title
GB2163150B (en) 3-aminopropoxyaryl derivatives
GB2152033B (en) Sulfonamido-benzamide derivatives
EP0163324A3 (en) Aminoalkylphenoxy derivatives
GB2155925B (en) Pyrimidylpiperazine derivatives
GB2164644B (en) Benzonorbornene derivatives
DE3565267D1 (en) 9a-aza-9a-homoerythromycin derivatives
GB8528226D0 (en) Flavolignan derivatives
GB2159814B (en) Iminothiazolidine derivatives
GB2165845B (en) Dioxinopyridine derivatives
GB8505028D0 (en) 3-exomethylenecepham derivatives
GB2165247B (en) Azabicycloheptene derivatives
GB2162178B (en) 4-cyano-3-oxo-hexahydro-isoquinoline derivatives
GB8419223D0 (en) Sulphamoylguanidine derivatives
EP0174271A3 (en) Anthraceme derivatives
GB2158066B (en) Apovincaminol derivatives
GB8503123D0 (en) Phenylpropargylamine derivatives
GB8422379D0 (en) Derivatives
GB8507663D0 (en) Thiatriazine derivatives
GB2169290B (en) Pyrone -3- carboxamide derivatives
GB8401010D0 (en) Thioketene derivatives
GB8428530D0 (en) 4-thioandrostene derivatives
GB2165243B (en) 17-sulphonamido yohimbane derivatives
GB8419224D0 (en) Sulphamoylguanidine derivatives
GB8407896D0 (en) Thiatriazine derivatives
GB8424767D0 (en) Yohimbane derivatives